Cytokinetics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CEORobert I. Blum
CEORobert I. Blum
Employees423
Employees423
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1997
Founded1997
Employees423
Employees423
CYTK Key Statistics
Market cap7.01B
Market cap7.01B
Price-Earnings ratio-12.29
Price-Earnings ratio-12.29
Dividend yield—
Dividend yield—
Average volume1.04M
Average volume1.04M
High today$68.53
High today$68.53
Low today$66.84
Low today$66.84
Open price$67.50
Open price$67.50
Volume894.74K
Volume894.74K
52 Week high$110.25
52 Week high$110.25
52 Week low$25.98
52 Week low$25.98
CYTK News
TipRanks 7d
Cytokinetics put volume heavy and directionally bearish - TipRanks.com - TipRanksBearish flow noted in Cytokinetics with 1,040 puts trading, or 1.2x expected. Most active are Apr-24 70 puts and Apr-24 76 calls, with total volume in those str...
Analyst ratings
83%
of 18 ratingsBuy
83.3%
Hold
16.7%
Sell
0%